The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$200,000+”, duration to "September 2016” and “September 2016” and All Insider Sales to “$5,000,000+”.
According to the above filters, the following are recent buys and sells from company insiders in the past week.
On Sept. 8, Felix Baker, director and part-owner of Seattle Genetics Inc. (SGEN), bought 414,016 shares at the price of $48.43 per share. Since then, the price of the stock has risen by 4.3% to $50.50.
The company has an insider ownership of 1.35% and institutional ownership of 96.09%. It is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
Over the past 12 months, the price of the stock has risen by 22% and is now trading with a price-book (P/B) ratio of 10.60. The price is 94.08% above its 52-week low.
On Sept. 7, Corp Penske, part-owner, and Roger S. Penske, chairman and CEO of Penske Automotive Group Inc. (PAG), bought 450,000 shares in the company at the price of $46.95 per share. Since then, the price of the stock has risen by 3.4% to $48.56.
The company has an insider ownership of 2.49% and institutional ownership of 40.03%. It is a transportation services company. It operates automotive and commercial vehicle dealerships in the United States and Western Europe and distributes commercial vehicles, diesel engines and related parts.
Over the past 12 months, the price of the stock has dropped 7% and is now trading with a P/B ratio of 2.37. The price is 10.49% below its 52-week high and 62.82% above its 52-week low.
On Sept. 7, Laboratory Corp of America Hol, part-owner of Sequenom Inc. (SQNM), bought 36,649,440 shares in the company at the price of $2.40 per share. Since then, the price of the stock has dropped by 0.4% to $2.39.
The company has an insider ownership of 2.10% and institutional ownership of 45.80%. It is a molecular diagnostic testing and genetics analysis company which provides molecular diagnostic testing services.
Over the past 12 months, the price of the stock has risen by 14% and the price is 5.53% below its 52-week high and 191.46% above its 52-week low.
On Sept. 7, Dennis K. Eck, director of Ulta Salon Cosmetics & Fragrance Inc. (ULTA), bought 11,00 shares in the company at the price of $246.97 per share. Since then, the price of the stock has dropped by 1.9% to $242.28.
The company has an insider ownership of 5.07% and institutional ownership of 86.60%. It is a beauty retailer that provides one-stop shopping for salon products and salon services in the United States. Its brands include Bare Minerals and Urban Decay prestige cosmetics.
Over the past 12 months, the price of the stock has risen by 47% and is now 12.85% below its 52-week high and 65.45% above its 52-week low.
Most Important Sales of the Week
On Sept. 8, Jan Koum, director of Facebook Inc Class A. (FB), sold 1,566,668 shares in the company at the price of $129.70 per share. Since then, the price of the stock has risen by 0.4% to $130.27.
The company has an institutional ownership of 56.56% and insider ownership of 0.36%. It operates a social networking website. The company's products are Facebook, Instagram, Messenger, WhatsApp and Oculus. Its products enable people to connect and share through mobile devices and personal computers.
Over the past 12 months, the price of the stock has risen by 44% and is now trading with a P/B ratio of 7.42. The price is 1.30% below its 52-week high and 51.97% above its 52-week low.
On Sept. 7, Richard Martin Steeves ,director of STERIS PLC. (STE), sold 204,778 shares in the company at the price of $71.19 per share. Since then, the price of the stock has dropped by 0.1% to $71.15.
The company has an institutional ownership of 90.58% and insider ownership of 0.69%. It is a provider of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical and research.
Over the past 12 months, the price of the stock has risen by 12% and is now trading with a P/B of 2.03. The price is 9.31% below its 52-week high and 16.39% above its 52-week low.
On Sept. 6, Gregory R. Pearson, senior vice president and general manager of the Sales & Marketing Group of Intel Corp. (INTC), sold 250,192 shares in the company at the price of $36.50 per share. Since then, the price of the stock has dropped by 0.2% to $36.44.
The company has an institutional ownership of 64.50% and insider ownership of 0.15%. It is a semiconductor chip maker. It develops integrated digital technology products, like integrated circuits, for industries such as computing and communications.
Over the past 12 months, the price of the stock has risen by 24% and is now trading with a P/B ratio of 2.80. The price is 0.52% below its 52-week high and 31.72% above its 52-week low.
Disclosure: I do not own any shares of any stocks mentioned in this article.
Start a free 7-day trial of Premium Membership to GuruFocus.
